2.12
price down icon1.85%   -0.04
 
loading
Schlusskurs vom Vortag:
$2.16
Offen:
$2.16
24-Stunden-Volumen:
68,197
Relative Volume:
1.16
Marktkapitalisierung:
$64.63M
Einnahmen:
$300.00K
Nettoeinkommen (Verlust:
$-40.16M
KGV:
-1.6092
EPS:
-1.3174
Netto-Cashflow:
$-42.36M
1W Leistung:
-7.42%
1M Leistung:
-1.40%
6M Leistung:
-12.76%
1J Leistung:
-14.86%
1-Tages-Spanne:
Value
$2.10
$2.22
1-Wochen-Bereich:
Value
$2.10
$2.33
52-Wochen-Spanne:
Value
$2.09
$3.44

Xbiotech Inc Stock (XBIT) Company Profile

Name
Firmenname
Xbiotech Inc
Name
Telefon
512-386-2900
Name
Adresse
5217 WINNEBAGO LANE, AUSTIN, TX
Name
Mitarbeiter
85
Name
Twitter
@xbiotech_usa
Name
Nächster Verdiensttermin
2026-11-11
Name
Neueste SEC-Einreichungen
Name
XBIT's Discussions on Twitter

Compare XBIT vs VRTX, MRNA, REGN, ARGX, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
XBIT icon
XBIT
Xbiotech Inc
2.12 64.63M 300.00K -40.16M -42.36M -1.3174
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
499.74 126.66B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
218.01 87.04B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
790.74 81.41B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
819.14 51.51B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
369.06 41.75B 5.76B 514.49M 1.10B 4.4813

Xbiotech Inc Stock (XBIT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2019-06-14 Eingeleitet Piper Jaffray Overweight
2017-04-21 Herabstufung Noble Financial Buy → Hold
2016-06-28 Bestätigt Noble Financial Buy

Xbiotech Inc Aktie (XBIT) Neueste Nachrichten

pulisher
Oct 08, 2026

XBIT Forecast — Price Target — Prediction for 2027 - TradingView

Oct 08, 2026
pulisher
Oct 03, 2026

XBiotech, Inc. Actuals & Estimates (SWB:4XB) - TradingView

Oct 03, 2026
pulisher
Oct 02, 2026

XBiotech Inc. SEC Filing (Oct 2, 2026) - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

$17.3M in severance is part of a former CEO's 2025 compensation at XBiotech (XBIT). - Stock Titan

Oct 02, 2026
pulisher
Sep 18, 2026

Xbiotech Stock Price Forecast. Should You Buy XBIT? - StockInvest.us

Sep 18, 2026
pulisher
Sep 03, 2026

XBiotech (NASDAQ:XBIT) Shares Cross Below 200-Day Moving AverageTime to Sell? - MarketBeat

Sep 03, 2026
pulisher
Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Supply Zone - vinanet.vn

Sep 01, 2026
pulisher
Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Sector ETF Flow - careplusvn.com

Sep 01, 2026
pulisher
Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Island Reversal - dars.gov.et

Sep 01, 2026
pulisher
Sep 01, 2026

XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08OBV Trend Line - dars.gov.et

Sep 01, 2026
pulisher
Aug 26, 2026

XBiotech (NASDAQ:XBIT) Share Price Passes Above 50 Day Moving AverageHere's What Happened - MarketBeat

Aug 26, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - vinanet.vn

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseEarly Entry Signals - vinanet.vn

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseLinear Regression - dars.gov.et

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseRevenue Growth Outlook - dars.gov.et

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - siam.in

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - dars.gov.et

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseMomentum ETF - careplusvn.com

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseProfitability Analysis - dars.gov.et

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseEarnings Call Q&A - www.dars.gov.et

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseInitial Balance - dars.gov.et

Aug 24, 2026
pulisher
Aug 24, 2026

XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseBull Flag - dars.gov.et

Aug 24, 2026
pulisher
Aug 13, 2026

XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - marketscreener.com

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - AOL.com

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - Enidnews.com

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - KTVB

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech (NASDAQ: XBIT) trims R&D spend yet remains loss-making in Q2 2026 - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - Barchart.com

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech (XBIT) Earnings Date and Reports 2026 $XBIT - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

XBiotech: Q2 Earnings Snapshot - Yahoo Finance

Aug 13, 2026
pulisher
Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceOverbought Signal Alerts - careplusvn.com

Aug 11, 2026
pulisher
Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceRip Sell Trade - dars.gov.et

Aug 11, 2026
pulisher
Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceActive ETF Flow - dars.gov.et

Aug 11, 2026
pulisher
Aug 11, 2026

XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceJelly Roll Trade - dars.gov.et

Aug 11, 2026
pulisher
Aug 10, 2026

XBiotech Inc (XBIT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 10, 2026
pulisher
Aug 07, 2026

XBiotech Inc (XBIT) Stock News Today - TradingKey

Aug 07, 2026
pulisher
Jul 30, 2026

XBiotech (NASDAQ:XBIT) Share Price Crosses Below 200-Day Moving AverageWhat's Next? - MarketBeat

Jul 30, 2026
pulisher
Jul 28, 2026

XBiotech Inc (XBIT) Income Statement - TradingKey

Jul 28, 2026
pulisher
Jul 27, 2026

XBiotech Inc (XBIT) Institutional Confidence - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBiotech Inc (XBIT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBiotech Inc (XBIT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBiotech Inc (XBIT) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBIT|XBiotech Inc|Price:2.300|Chg%:+0.030 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBiotech Inc (XBIT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBiotech Inc (XBIT) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBiotech Inc (XBIT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBiotech Inc (XBIT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

XBIT|XBiotech Inc|Price:2.270| - TradingKey

Jul 27, 2026

Finanzdaten der Xbiotech Inc-Aktie (XBIT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Kapitalisierung:     |  Volumen (24h):